(Q50553161)

English

Incidence and impact on mortality of severe neurocognitive disorders in persons with and without HIV infection: a Danish nationwide cohort study.

scientific article published in January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21288850

Incidence and impact on mortality of severe neurocognitive disorders in persons with and without HIV infection: a Danish nationwide cohort study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21288850

9

object named as

Niels Obel

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

author name string

François-Xavier Lescure

1

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21288850

Lars Haukali Omland

2

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21288850

Frederik Neess Engsig

3

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21288850

Casper Roed

4

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21288850

Jan Gerstoft

5

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21288850

Gilles Pialoux

6

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21288850

Gitte Kronborg

7

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21288850

Carsten Schade Larsen

8

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21288850

language of work or name

0 references

publication date

1 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21288850

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21288850

52

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21288850

2

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21288850

235-243

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21288850

Correlates of lending needles/syringes among HIV-seropositive injection drug users

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Survival of persons with and without HIV infection in Denmark, 1995-2005.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Antiretroviral therapy and central nervous system HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

The prevalence and incidence of neurocognitive impairment in the HAART era.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Changing incidence of central nervous system diseases in the EuroSIDA cohort

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Changes in pathological findings at autopsy in AIDS cases for the last 15 years

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Cerebral FDG-PET scanning abnormalities in optimally treated HIV patients

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Influence of highly active antiretroviral therapy on persistence of HIV in the central nervous system

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Cohort profile: the Danish HIV cohort study.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Epidemiology. When an entire country is a cohort

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Updated research nosology for HIV-associated neurocognitive disorders

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Effects of antiretroviral treatment on blood-brain barrier integrity and intrathecal immunoglobulin production in neuroasymptomatic HIV-1-infected patients.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

HIV and antiretroviral therapy in the brain: neuronal injury and repair

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Neuropathologic contributions to understanding AIDS and the central nervous system

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

The epidemiology of the dementias: an update

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

What policymakers should know about drug resistance and adherence in the context of scaling-up treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ041

21 January 2018

Identifiers

10.1093/CID/CIQ041

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21288850

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21288850

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50553161&oldid=981721176"